Early breast tomosynthesis adopter Washington Radiology Associates increased cancer detection by one-third, decreased call-backs, and improved provider confidence.
At Washington Radiology Associates, staying on the leading edge of women’s imaging technology is a priority, so the group wanted to be an early adopter of 3-D breast tomosynthesis.
The six-location group in the Washington, DC area eventually replaced all 15 of their Hologic Selenia 2-D mammography machines with the Hologic Dimensions product, on which they could add the tomosynthesis software.
After a three month trial with two tomography upgrades, “our doctors were convinced this technology was beneficial for our patients,” said Patrick Waring, administrator for Washington Radiology Associates. Last June, the group completed the upgrade of 15 Dimensions 3-D tomography machines.
Washington Radiology Associates has chosen to charge customers a fee, since it’s not yet a reimbursable service. Tomosynthesis is offered to all patients - not just those with dense breasts, for example - and a large percentage of patients choose tomo, Waring said.
Radiologists at Washington Radiology Associates have increased their cancer detection rate by about a third, said Mark Klein, MD. Call-back rates have also diminished, depending on the radiologists, but likely on average about a third, too.
Equally important, Klein said, is the reduced anxiety for the radiologist that comes with reading a study with greater certainty. “Your confidence level goes way up,” he said. “When you’re finished reading a 3-D mammogram and you think it’s normal, you’re probably right. That’s a real advantage.”
In addition to the benefits to radiologists and patients, the addition of tomosynthesis is a differentiator for the practice. “If you’re not the first [to offer tomosynthesis], the guy down the street will be,” Waring said. “This is technology that will be here to stay.”
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Mammography Study: AI Facilitates Greater Accuracy and Longer Fixation Time on Suspicious Areas
July 8th 2025While noting no differences in sensitivity, specificity or reading time with adjunctive AI for mammography screening, the authors of a new study noted a 4 percent higher AUC and increased fixation time on lesion regions.
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
June 17th 2025While the addition of contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) led to over a 13 percent increase in false positive cases, researchers also noted over double the cancer yield per 1,000 women in comparison to DBT alone.
Contrast-Enhanced Mammography and High-Concentration ICM Dosing: What a New Study Reveals
June 16th 2025New research showed a 96 to 97 percent sensitivity for contrast-enhanced mammography (CEM) with an increased iodine delivery rate facilitating robust contrast enhancement for women with aggressive breast cancer.